Amgen Inc - Jan 6, 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
10%+ Owner
Signature
/s/ Andrea A. Robinson, Vice President, Law, Governance and Securities & Assistant Secretary
Stock symbol
VIGL
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 07:39 PM
Previous filing
Sep 13, 2021
Next filing
Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Series A Preferred Stock Jan 6, 2022 Common Stock 3.21M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series A Preferred Stock are convertible into shares of the Issuer's common stock on a one-for-2.7732 basis and, upon completion of the Issuer's initial public offering, will automatically convert into the number of shares of the Issuer's common stock shown in Column 3.
F2 10% beneficial ownership is calculated in accordance with SEC rules based on the number of shares of the Issuer's common stock outstanding on the date hereof and the conversion of only the reporting person's shares of preferred stock.